What medications does Abbvie produce?

Abbvie, a global biopharmaceutical company, produces a diverse range of medications used to treat various medical conditions. The company is particularly well-known for its innovative therapies in areas such as immunology, oncology, virology, and neuroscience. One of its flagship products is Humira, a highly prescribed biologic medication that is used to treat several autoimmune conditions, including rheumatoid arthritis, ankylosing spondylitis, and Crohn's disease. In the field of oncology, Abbvie offers therapies such as Imbruvica, which is utilized for certain types of blood cancers, and Venclexta, used for chronic lymphocytic leukemia. Additionally, in virology, Abbvie has developed Mavyret, a medication for the treatment of hepatitis C. In the realm of neuroscience, Abbvie markets the medication Ubrelvy for the acute treatment of migraine. Abbvie's extensive pipeline signifies their commitment to developing new therapies. Their research and development efforts focus on finding solutions for some of the most challenging health problems faced today. To explore a more comprehensive list of Abbvie's medications and any updates on their product offerings, it would be beneficial for individuals to visit Abbvie's official website, where they provide detailed information about their current medications and ongoing research initiatives.